Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy

Medicine

Volumn 85, Issue 4, 2006, Pages 229-238

  Delahaye, Nicolas ^a   Rouzet, François ^a   Sarda, Laure ^a,b   Tamas, Carmen ^b   Dinanian, Sylvie ^c   Plante Bordeneuve, Violaine ^d   Adams, David ^d   Samuel, Didier ^e   Merlet, Pascal ^a   Syrota, André ^b   Slama, Michel S ^c   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

^b DIF   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d BICÊTRE HOSPITAL   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMYLOID; METHIONINE; METHIONINE 30; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTONOMIC DENERVATION; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG UPTAKE; ECHOCARDIOGRAPHY; EVALUATION; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENE MUTATION; HEART AMYLOIDOSIS; HEART DENERVATION; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; IMAGING; LIVER TRANSPLANTATION; MALE; MEASUREMENT; MEDIASTINUM; NEUROPATHY; PATIENT ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; SYMPATHETIC NERVE; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ADULT; AMYLOID NEUROPATHIES, FAMILIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART; HEART CATHETERIZATION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM;

EID: 33746271575     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000232559.22098.c3     Document Type: Article

References (48)

1. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain. 2000;123:1495-1504.
2. Alexopoulos D, Yusuf S, Johnston JA, Bostock J, Sleight P, Yacoub MH. The 24-hour heart rate behavior in long-term survivors of cardiac transplantation. Am J Cardiol. 1988;61:880-884.
3. Andersson K, Olofsson A, Nielsen EH, Svehag SE, Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun. 2002;294:309-314.
4. Andrade C. A peculiar form of peripheral neuropathy: familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408-427.
5. Bengel FM, Ueberfuhr P, Hesse T, Schiepel N, Ziegler SI, Scholz S, Nekolla SG, Reichart B, Schwaiger M. Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation. Circulation. 2002;106:831-835.
6. Bengel FM, Ueberfuhr P, Ziegler SI, Nekolla SG, Reichart B, Schwaiger M. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation. 1999;99:1866-1871.
7. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology. 1996;47:944-951.
8. Bergfeldt BL, Olofsson BO, Edhag KO. Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol. 1985;56:647-652.
9. Bittencourt PL, Couto CA, Farias AQ, Marchiori P, Bosco Massarollo PC, Mies S. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil. Liver Transpl. 2002;8:34-39.
10. Coelho E, Pimentel JC. Cardiac involvement in a peculiar form of paramyloidosis. Am J Cardiol. 1961;8:624-632.
11. Coutinho CA, Conceicao I, Almeida A, Cantinho G, Sargento L, Vagueiro MC. Early detection of sympathetic myocardial denervation in patients with familial amyloid polyneuropathy type I. Rev Port Cardiol. 2004;23:201-211.
12. Dae MW, De Marco T, Botvinick EH, O'Connel JW, Hattner RS, Huberty JP, Yuen-Green MS. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts. Implications for clinical studies. J Nucl Med. 1992;33:1444-1450.
13. De Marco T, Dae M, Yuen-Green MSF, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, Botvinick EH, Chatterjee K. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol. 1995;25:927-931.
14. Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, Merlet P, Le Guludec D. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999;26:416-424.
15. Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, Dolle F, Mzabi H, Samuel D, Adams D, Syrota A, Merlet P. Myocardial muscarinic receptor up-regulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation. 2001;104:2911-2916.
16. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation. 1997;64:74-80.
17. Eriksson A, Eriksson P, Olofsson BO, Thornell LE. The cardiac atrioventricular conduction system in familial amyloidosis wih polyneuropathy. A clinico-pathologic study of six cases from northern Sweden. Acta Pathol Microbiol Immunol Scand [A]. 1983;91:343-349.
18. Eriksson P, Karp K, Bjerle P, Olofsson BO. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J. 1984;51:658-662.
19. Falcao de Freitas A. The heart in Portuguese amyloidosis. Postgrad Med J. 1986;62:601-605.
20. Green NS, Foss TR, Kelly JW. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc Natl Acad Sci U S A. 2005;102:14545-14550.
21. Hammarstrom P, Wiseman RL, Powers ET, Kelly JW. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science. 2003;299:713-716.
22. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341:1113-1116.
23. Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci. 1987;79:129-139.
24. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
25. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, Loisance D, Castaigne A, Syrota A. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999;40:917-923.
26. Merlet P, Caussin C, Poiseau E, Piot O, Maziere B, Syrota A. In vivo assessment of neurotransmitter system in cardiovascular diseases. Q J Nucl Med. 1996;40:108-120.
27. Miller SR, Sekijima Y, Kelly JW. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest. 2004;84:545-552.
28. Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Cescon M, Grazi GL, Salvi F, Magelli C, Grigioni F, Arpesella G, Martinelli G, Cavallari A. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant Proc. 2004;36:645-647.
29. Niklasson U, Olofsson BO, Bjerle P. Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand. 1989;79:182-187.
30. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98:1510-1516.
31. Nyhlin N, Anan I, El Salhy M, Ando Y, Suhr OB. Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy. J Intern Med. 2002;251:136-141.
32. Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand. 1980;208:77-80.
33. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation. 2002;73:745-751.
34. Olofsson BO, Bjerle P, Osterman G. Hemodynamic and angiocardiographic observations in familial amyloidosis with polyneuropathy. Acta Med Scand. 1982;212:77-81.
35. Parrilla P, Lopez-Andreu FR, Ramirez P, Bueno FS, Robles R, Miras M, Escribano JB, Vicente J, Acosta F, Munar Ques M, Costa PP, Teixera A. Familial amyloidotic polyneuropathy type I (Andrade's disease): a new indication for liver transplant. Transplantation. 1994;57:473-475.
36. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998;65:918-925.
37. Schnell O, Muhr D, Weiss M, Kirsch CM, Haslbeck M, Tatsch K, Standl E. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. J Diabetes Complications. 1997;11:307-313.
38. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. Transplantation. 1998;66:229-233.
39. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl. 2002;8:787-794.
40. Suhr OB, Wiklund U, Ando Y, Ando E, Olofsson BO. Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability. J Intern Med. 1997;242:225-229.
41. Suhr OB. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid. 2003;10(Suppl 1):77-83.
42. Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol. 1991;22:519-527.
43. Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, Isobe M, Sekiguchi M. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of cardiac sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1997;29:168-174.
44. Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17:354-381.
45. Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid. 2003;10(Suppl 1):48-54.
46. Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid. Muscle Nerve. 2003;28:438-442.
47. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun. 2000;274:702-706.
48. Ziegler D, Weise F, Langen KJ, Piolot R, Boy C, Hubinger A, Muller-Gartner HW, Gries FA. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia. 1998;41:443-451.